Suppr超能文献

血钙正常的原发性甲状旁腺功能亢进症患者的小梁骨评分

TRABECULAR BONE SCORE IN PATIENTS WITH NORMOCALCEMIC HYPERPARATHYROIDISM.

作者信息

Díaz-Soto Gonzalo, de Luis Román Daniel, Jauregui Olatz Izaola, Briongo Laisa, Romero Enrique, Pérez-Castrillón José Luis

出版信息

Endocr Pract. 2016 Jun;22(6):703-7. doi: 10.4158/EP151055.OR. Epub 2016 Feb 1.

Abstract

OBJECTIVE

The effects of normocalcemic hyperparathyroidism (NHPT) on bone remain unclear. The objective of this study was to evaluate differences in the trabecular bone score (TBS) of NHPT patients and asymptomatic hypercalcemic hyperparathyroidism (HHPT) patients.

METHODS

We performed a prospective study that enrolled consecutive patients with asymptomatic hyperparathyroidism (NHPT and HHPT) with a follow-up ≥1 year at the University Hospital of Valladolid, Spain. Metabolic phosphocalcium plasma and urine parameters were evaluated in ≥2 determinations during follow-up to classify patients as NHPT patients or asymptomatic HHPT patients. A control group was enrolled during the same period. TBS and bone mineral density (BMD) were evaluated.

RESULTS

Thirty-nine patients with asymptomatic HPT (24 with NHPT and 15 with HHPT) and 24 controls were recruited. NHPT patients and HHPT patients had a similar mean age, vitamin D level, TBS, and areal BMD (all sites). Compared to controls, symptomatic HPT patients had significantly higher parathyroid hormone (PTH) and calcium levels and significantly lower TBS and areal BMD at all sites (all P<.05). A significant negative relationship between TBS and PTH was found in asymptomatic HPT patients (r = -0.320, P = .043), which remained significant after adjustment for age, sex, and body mass index.

CONCLUSION

There was no difference in the TBS between NHPT and HHPT patients. However, there was a reduction in the TBS of patients with asymptomatic HPT that was related to PTH levels but had no repercussion on bone mass. Higher levels of PTH seem to be responsible for this alteration in microarchitecture texture.

ABBREVIATIONS

aBMD = areal bone mineral density BMD = bone mineral density BMI = body mass index DXA = dual-energy X-ray absorptiometry HHPT = hypercalcemic hyperparathyroidism HPT = hyperparathyroidism HR-MRI = high-resolution magnetic resonance HR-pQcT = high-resolution peripheral quantitative computed tomography NHPT = normocalcemic hyper-parathyroidism PTH = parathyroid hormone TBS = trabecular bone score 25vitD = 25-hydroxyvitamin D.

摘要

目的

血钙正常的甲状旁腺功能亢进症(NHPT)对骨骼的影响尚不清楚。本研究的目的是评估NHPT患者和无症状高钙血症性甲状旁腺功能亢进症(HHPT)患者的小梁骨评分(TBS)差异。

方法

我们在西班牙巴利亚多利德大学医院进行了一项前瞻性研究,纳入连续的无症状甲状旁腺功能亢进症患者(NHPT和HHPT),随访时间≥1年。在随访期间进行≥2次测定,评估代谢性磷钙血浆和尿液参数,以将患者分类为NHPT患者或无症状HHPT患者。同期纳入一个对照组。评估TBS和骨密度(BMD)。

结果

招募了39例无症状甲状旁腺功能亢进症患者(24例NHPT患者和15例HHPT患者)和24例对照。NHPT患者和HHPT患者的平均年龄、维生素D水平、TBS和面积骨密度(所有部位)相似。与对照组相比,有症状的甲状旁腺功能亢进症患者的甲状旁腺激素(PTH)和钙水平显著更高,所有部位的TBS和面积骨密度显著更低(所有P<.05)。在无症状甲状旁腺功能亢进症患者中,发现TBS与PTH之间存在显著负相关(r = -0.320,P = .043),在调整年龄、性别和体重指数后仍具有显著性。

结论

NHPT患者和HHPT患者的TBS没有差异。然而,无症状甲状旁腺功能亢进症患者的TBS降低与PTH水平有关,但对骨量没有影响。较高水平的PTH似乎是这种微观结构质地改变的原因。

缩写

aBMD = 面积骨密度;BMD = 骨密度;BMI = 体重指数;DXA = 双能X线吸收法;HHPT = 高钙血症性甲状旁腺功能亢进症;HPT = 甲状旁腺功能亢进症;HR-MRI = 高分辨率磁共振成像;HR-pQcT = 高分辨率外周定量计算机断层扫描;NHPT = 血钙正常的甲状旁腺功能亢进症;PTH = 甲状旁腺激素;TBS = 小梁骨评分;25vitD = 25-羟基维生素D

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验